Wira Eka Putra, Wa Ode Salmac And Diana Widiastuti

Judul	:	THE POTENCY OF BOESENBERGIN A AND BOESENBERGIN B COMPOUNDS FROM Kaempferia pandurata AS ANTI-METASTATIS AGENT: IN SILICO STUDY
Abstrak	:	Metastasis is hallmark of the cancer. Recently, targeting molecules that are responsible in promoting metastasis might be one of favorable strategies. In this study, we aimed to evaluate bioactive compounds of Kaempferia pandurata rhizome as anti-metastasis against NF-κB. Molecular docking and molecular interaction among ligands and target protein were applied in this study. Importantly, we found the greatest substances which might possible to become inhibitor to NF-κB. Boesenbergin A and B were predicted to have the favorable interaction scores, -8.2 kcal/mol and -7.1 kcal/mol, respectively. More detail, boesenbergin A has certain interaction to residual amino acids such as GLU160, ASP121, THR153, SER113, LYS149, VAL145, HIS144, THR146, TYR60, ALA62, VAL61, HIS112, ALA111, LEU143, ALA156, ARG157. While the boesenbergin B has interaction to residual amino acids such as SER249, PHE310, LEU272, VAL254, HIS307, ARG308, ALA311, ASP274, CYS273, LYS275, LYS244. In the future, further research is necessary to confirm and validate the biological activities of boesenbergin A and B, especially in metastasis incidence.
Tahun	:	2020	Media Publikasi	:	Jurnal Internasional
Kategori	:	Jurnal	No/Vol/Tahun	:	MJBMB, 2020, 128 - 132 / 3 / 2020
ISSN/ISBN	:	15112616
PTN/S	:	Universitas Pakuan	Program Studi	:	KIMIA
Bibliography	:	Riihimäki, M., Thomsen, H., Hemminki, A., Sundquist, K., and Hemminki, H. (2013). Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. BMC Cancer. 13, 1-8. 2. Seyfried, T.N., and Huysentruyt, L.C. (2013). On the Origin of Cancer Metastasis. Crit Rev Oncog. 18(1-2), 43–73. 3. Lu, C.C., Yang, J.S., Chiang, J.H., Hour, M.J., Amagaya, S., Lu, K.W., Lin, J.P., Tang, N.Y., Lee, T.H., and Chung, J.G. (2012). Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling. Anticancer Res. 32(7), 2895-2903. 4. Radisky, E.S., and Radisky DC. (2015). Matrix metalloproteinases as breast cancer drivers and therapeutic targets. Front Biosci (Landmark Ed). 20, 1144-1163. 5. Shay, G., Lynch, C.C., and Fingleton, B. (2015). Moving targets: Emerging roles for MMPs in cancer progression and metastasis. Matrix Biol. 44-46, 200-206. 6. Bond, M., Chase, A.J., Baker, A.H., and Newby, A.C. (2001). Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res. 50(3), 556-565. 7. Pavlaki, M., and Zucker, S. (2003). Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials. Cancer Metastasis Rev. 22(2-3), 177-203. 8. Coussens, L.M., Fingleton, B., and Matrisian, L.M. (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 295(5564), 2387-2392. 9. Sukandar, E.Y., Sunderam, N., and Fidrianny, I. (2014). Activity of Kaempferia pandurata (Roxb.) rhizome ethanol extract against MRSA, MRCNS, MSSA, Bacillus subtilis and Salmonella typhi. Pak J Biol Sci. 17(1), 49-55. 10. Lipinski, C.A. (2004). Lead- and drug-like compounds: the rule-offive revolution. Drug Discov Today Technol. 1(4), 337-341.MJBMB, 2020, 3, 128 - 132 - 132 - 11. Trott, O., and Olson, A.J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 31(2), 455–461. 12. Putra, W.E., Agustin, F., Rochmatika, L., and Salma, WO. (2019). Potential of Indonesian medicinal plants as anti-cancer: In silico study. Malaysian J Biochem Mol Biol. 22(1), 152-154. 13. Putra, W.E. (2018). In silico study demonstrates multiple bioactive compounds of sambucus plant promote death cell signaling pathway via Fas receptor. FUW Trends in Science & Technology Journal. 2(3), 682-685. 14. Putra, W.E., Salma W.O., and Rifa'i, M. (2019). Anti-inflammatory activity of sambucus plant bioactive compounds against TNF-α and TRAIL as solution to overcome inflammation associated diseases: The insight from bioinformatics study. Nat Prod Sci. 25(3), 215-221. 15. Orlowski, R.Z., and Baldwin, A.S.J. (2002). NF-kappaB as a therapeutic target in cancer. Trends Mol Med. 8(8), 385-389. 16. Baud, V., and Karin, M. (2009). Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov. 8(1): 33–40. 17. Liu, T., Zhang, L., Joo, D., Sun, S-C. (2017). NF-κB signaling in inflammation. Sig Transduct Target Ther. 2(17023), 1-9. 18. Albensi, B.C. (2019). What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? Front Cell Dev Biol. 7(154), 1-7. 19. Atkin, P. and Paula, D.J. (2006). Physical Chemistry 8th Edition. New York: W.H. Freeman and Company. 20. Isa NM, Abdelwahab SI, Mohan S, Abdul AB, Sukari MA, Taha MM, Syam S, Narrima P, Cheah SCh, Ahmad S, Mustafa MR. (2012). In vitro anti-inflammatory, cytotoxic and antioxidant activities of boesenbergin A, a chalcone isolated from Boesenbergia rotunda (L.) (fingerroot). Braz J Med Biol Res. 45(6), 524-530
URL	:	https://msbmb2010.wixsite.com/mjbmb